The vaccine, jointly developed by the National Institute of Virology-Pune and Hyderabad-based Bharat Biotech International Limited (BBIL) in collaboration with the Indian Council of Medical ...

HYDERABAD: Hyderabad-based vaccine manufacturer Bharat Biotech International Limited (BBIL) on Tuesday announced the launch ...

Sai Prasad, Executive Director, Bharat Biotech International Limited (BBIL) told the news agency that Covaxin was found to be safe without any major adverse events in the first two stages of the ...

Dr Krishna Ella, Executive Chairman, Bharat Biotech International Limited speaking to Prathiba Raju on the sidelines of ETPharma’s inaugural Next-Gen LabCon Conference discusses the global ...

Together with Bharat Biotech International Ltd, we aim to make a lasting impact on global health." Bharat Biotech had played a key role in the combat against COVID-19 with its indigenously ...

India has approved its first nasal Covid vaccine. Made by Bharat Biotech, iNCOVACC is administered in the form of drops and stimulates an immune response in the tissues that line the nasal cavity.

As part of the Phase II/III trial, the two-dose Covaxin was administered with 28 days apart. Bharat Biotech, which completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children ...

The Andhra Pradesh government has formed a new board for the Tirumala Tirupati Devasthanams, consisting of 24 members. Bollineni Rajgopal Naidu has been appointed as chairman. Suchitra Ella of Bharat ...

Guwahati: Institute of Advanced Study in Science and Technology (IASST), Guwahati on Thursday signed a crucial R&D collaboration agreement with Bharat Biotech International Ltd (BBIL), Hyderabad.

While Bharat Biotech, a global leader in vaccine and health solutions, will conduct pre-clinical and clinical trials, the IASST will contribute its scientific understanding and spearhead the ...

Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise. Bright Minds shares DRUG ...

Bharat Biotech inks deal with Precisa Medicamentos for supply of COVAXIN to Brazil Bharat Biotech has informed that the supplies of Covaxin will be prioritised for the public market, through a ...